First-in-Human trial launches for silent uric acid condition
NCT ID NCT06859073
First seen Oct 31, 2025 · Last updated Jun 15, 2026 · Updated 31 times
Summary
This early-stage study tests an experimental drug, NNC4004-0002, in 60 adults with high uric acid levels but no symptoms. The main goal is to check safety and how the body handles a single injection. Participants receive either the drug or a placebo (saline) by chance. The study lasts about 7 months per person, with 14 clinic visits including a 4-night stay.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
PAREXEL Glendale/LA EPCU
NOT_YET_RECRUITINGGlendale, California, 91206, United States
-
PAREXEL Intl - EPCU-Baltimore
RECRUITINGBaltimore, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.